LAVA Announces Annual Meeting of Shareholders

Author's Avatar
May 30, 2023

UTRECHT, The Netherlands and PHILADELPHIA, May 30, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX) (LAVA), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabodyâ„¢ platform of bispecific gamma-delta T cell engagers, today announced the annual general meeting of shareholders will take place on Wednesday, June 14, 2023 at 2:00 p.m. CEST.